CLINUVEL Pharmaceuticals Limited (ASX:CUV) Reports Preliminary CUV052 Study Results
CLINUVEL (ASX:CUV) releases preliminary results from the CUV052 study, supporting SCENESSE®’s safety in adolescent EPP patients.
CLINUVEL (ASX:CUV) releases preliminary results from the CUV052 study, supporting SCENESSE®’s safety in adolescent EPP patients.
Terramin Australia (ASX:TZN) updates on the legal appeal and operational progress of its Bird in Hand Gold Project, highlighting significant economic benefits for South Australia.
PYC Therapeutics (ASX:PYC) receives regulatory approval to commence human trials for its PKD drug candidate, PYC-003.
Collins Foods (ASX:CKF) clarifies Yum! Brands’ Q4 sales growth, addressing comparability issues and regional inclusions.
Cannindah Resources (ASX:CAE) addresses ASX price query, affirming no undisclosed information impacting recent trading activities.
Godolphin Resources Limited (ASX:GRL) temporarily pauses trading pending further announcements.
Poseidon (ASX:POS) and Horizon Minerals (ASX:HRZ) secure court approval for their merger, effective 10 February 2025.
Nyrada Inc (ASX:NYR) has commenced its Phase Ia clinical trial for NYR-BI03, following HREC approval.
RLF AgTech Ltd (ASX:RLF) successfully raises $2.4M through its Entitlement Issue, demonstrating strong investor support and funding its growth strategy.
Australian Rare Earths (ASX:AR3) launches its 2025 drilling program at the Overland Uranium Project, targeting palaeovalley mapping and high-priority exploration areas.